what is nevasic?

Nevasic is a medical audio programme which stabilises the balance receptors in the inner ear in order to provide relief from nausea and sickness.


Nevasic delivers precisely engineered stabilising audio pulses and frequencies, presented in a jacket of music, to make consumption easy.
Many of the frequencies and pulses that desensitise and stabilise the Vestibular system are bordering our recognizable audio spectrum, but still have a profound effect on the ear. In other words your ear is still picking them up but you may not recognise it - much the same as a dog whistle, your ear receives it but you don't register it.
Nevasic is a new form of antiemetic, with no drugs, no chemicals and no side effects. Due to the nature of the product there are no age limits, no language barriers and no geographical barriers to its use and nevasic is re-usable and highly cost effective.
The Nevasic programme is effective for a wide range of conditions- whether you suffer from pregnancy sickness, travel sickness or sickness related to excesses, medical conditions and prescribed drugs.
A great thing about Nevasic is that it can be used at any time, in almost any place and because there is no need to lie down while using the programme you can use it while doing what you want to do!


Nevasic is Safe

Nevasic is 100% drug free, is not a hypnosis or relaxation product and does not contain subliminal messages. How to use Nevasic >
While Nevasic is proven for pregnancy sickness and motion sickness the antiemetic capabilities of the programme have been shown to be beneficial in a variety of situations where Emesis is the result of a condition or a treatment of a condition;


Clinical trial - Motion sickness

The MRC Spatial Disorientation Group, Imperial College School of Medicine, London ran a full clinical trial under the branded of TravelWell.

The trial proved conclusively that the programme is highly effective in combating the symptoms of nausea and vomiting associated with motion sickness.
The report from the trial is lodged with PubMed and available via the National Library of Medicine (USA).

NHS study - Morning sickness

Nevasic was studied by the UK NHS under the branded name of MorningWell.

The study was commissioned by;

Mr M J Heard FRCOG
Department of Obstetrics and Gynaecology
Royal Hampshire County Hospital
Winchester, UK.

Study Manager;

Midwife Mrs Lynne Mayo - SRN, SCM, - Andover NHS Birth Centre.


NHS research data.

A National Health Service (NHS) Study showed 9 out of 10 pregnant women experienced a reduction or elimination of their symptoms of nausea & vomiting in morning sickness by using Nevasic branded as MorningWell.

Nevasic is a registered class 1 Medical Device in the UK and the USA. It is also registered by the Australian Medical Devices Listing Section (Conformity Assessment Branch) as an exempt product under the Therapeutic Goods Act.


Nevasic is 100% drug free, is not a hypnosis or relaxation product and does not contain subliminal messages.

How to use Nevasic >

Motion sickness clinical trial

 

The MRC Spatial Disorientation Group, Imperial College School of Medicine, London ran a full clinical trial with nevasic branded as TravelWell.

The trial proved conclusively that the programme is highly effective in combating the symptoms of nausea and vomiting associated with motion sickness.

The report from the trial is lodged with PubMed and available via the National Library of Medicine (USA).

Here is the abstract report: 1: J Travel Med. 2003 Mar-Apr,10(2):108-11 Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and a music audiotape. Yen Pik Sang FD, Billar JP, Golding JF, Gresty MA. The MRC Spatial Disorientation Group, Imperial College School of Medicine, London, United Kingdom.

BACKGROUND: Behavioral countermeasures for motion sickness would be advantageous because of the side effects of antiemetic drugs, but few alternatives treatments are available. The objective of this study was to compare the effectiveness of controlling breathing and listening to a music audiotape designed to reduce motion sickness symptoms, on increasing tolerance to motion sickness.

METHOD: Twenty-four healthy subjects were exposed to nauseogenic Coriolis stimulation on a rotating turntable under three conditions: whilst focusing on controlling breathing; listening to a music audiotape; or without intervention (control). The three conditions were performed by each subject according to a replicated factorial design at 1-week intervals at the same time of day. Ratings of motion sickness were obtained every 30 seconds. Once a level of mild nausea was reached subjects commenced controlling breathing or listened to the music audiotape. Motion was stopped after the onset of moderate nausea.

RESULTS: Mean (+/- SD) motion exposure time in minutes tolerated before the onset of moderate nausea was significantly longer (p <.01) for controlling breathing (10.7 +/- 5.6 min) and longer (p <.01) for music (10.4 +/- 5.6 min) compared with control (9.2 +/- 5.9 min).

CONCLUSIONS: Both controlling breathing and the music audiotape provided significant protection against motion sickness. They are easy to implement and free of side effects.

Publication Types: Clinical Trial Controlled Clinical Trial

PMID: 12650654 [PubMed - indexed for MEDLINE] Click the below line or copy and paste it to your address bar to view this information direct within the pages of PubMed (United States National Library Of Medicine: http://www.ncbi.nlm.nih.gov

The report was published by the International Society of Travel Medicine (http://www.istm.org/). To obtain the correct report quote "Journal of Travel Medicine Volume: 10 • Issue: 02 • 2003 • March • Page: 108"

NHS morning sickness study

 

Nevasic was studied by the UK NHS under the branded name of MorningWell.

The study was commissioned by;
Mr M J Heard FRCOG
Department of Obstetrics and Gynaecology
Royal Hampshire County Hospital
Winchester, UK.

Study Manager - Midwife Mrs Lynne Mayo - SRN, SCM, - Andover NHS Birth Centre.

NHS research data.
A National Health Service (NHS) Study showed 9 out of 10 pregnant women experienced a reduction or elimination of their symptoms of nausea & vomiting in morning sickness by using nevasic branded as MorningWell.

If you prefer to buy MorningWell please visit  http://www.morningwell.co.uk.

As a result of the study MorningWell is still available as a CD and is distributed in the UK by The National Childbirth Trust.

As MorningWell is derived of Nevasic technology - you can gain the same benefits by using Nevasic.